ATE237586T1 - Verfahren zur herstellung von 16-dehydro vitamin d verbindungen - Google Patents

Verfahren zur herstellung von 16-dehydro vitamin d verbindungen

Info

Publication number
ATE237586T1
ATE237586T1 AT98201381T AT98201381T ATE237586T1 AT E237586 T1 ATE237586 T1 AT E237586T1 AT 98201381 T AT98201381 T AT 98201381T AT 98201381 T AT98201381 T AT 98201381T AT E237586 T1 ATE237586 T1 AT E237586T1
Authority
AT
Austria
Prior art keywords
compounds
alkyl
hydrogen
group
cycloalkyl
Prior art date
Application number
AT98201381T
Other languages
English (en)
Inventor
D Velde J P V
S J Halkes
J Zorgdrager
Los Angeles Rey M Del
A Mourino
Y Fall
K M Halkes
A Fernandez-Gacio
Original Assignee
Duphar Int Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Duphar Int Res filed Critical Duphar Int Res
Application granted granted Critical
Publication of ATE237586T1 publication Critical patent/ATE237586T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/76Unsaturated compounds containing keto groups
    • C07C59/90Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • C07F7/1872Preparation; Treatments not provided for in C07F7/20
    • C07F7/1892Preparation; Treatments not provided for in C07F7/20 by reactions not provided for in C07F7/1876 - C07F7/1888
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/14All rings being cycloaliphatic
    • C07C2602/24All rings being cycloaliphatic the ring system containing nine carbon atoms, e.g. perhydroindane
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT98201381T 1997-05-02 1998-04-28 Verfahren zur herstellung von 16-dehydro vitamin d verbindungen ATE237586T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97201334 1997-05-02

Publications (1)

Publication Number Publication Date
ATE237586T1 true ATE237586T1 (de) 2003-05-15

Family

ID=8228295

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98201381T ATE237586T1 (de) 1997-05-02 1998-04-28 Verfahren zur herstellung von 16-dehydro vitamin d verbindungen

Country Status (8)

Country Link
US (1) US6080878A (de)
EP (1) EP0884308B1 (de)
JP (1) JPH10316652A (de)
AT (1) ATE237586T1 (de)
DE (1) DE69813380T2 (de)
DK (1) DK0884308T3 (de)
ES (1) ES2196476T3 (de)
IL (1) IL124284A (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8404667B2 (en) * 2006-12-29 2013-03-26 Wisconsin Alumni Research Foundation Compounds, compositions, kits and methods of use to orally and topically treat acne and other skin conditions by 19-Nor vitamin D analog
US9221753B2 (en) 2004-02-03 2015-12-29 Chugai Seiyaku Kabushiki Kaisha Process for the synthesis of vitamin D compounds and intermediates for the synthesis of the compounds
CA2981549A1 (en) * 2009-01-27 2010-08-05 Berg Llc Vitamin d3 and analogs thereof for alleviating side effects associated with chemotherapy
WO2011002756A2 (en) * 2009-07-01 2011-01-06 Vitamin Derivatives, Inc. Vitamin d compounds and methods for preparing same
CN106265695B (zh) 2009-08-14 2021-05-07 博格有限责任公司 用于治疗脱发的维生素d3及其类似物
ES2396524B2 (es) * 2012-12-11 2013-08-01 Universidade De Santiago De Compostela Intermedios versátiles y funcionalizados en la síntesis de vitamina D y nuevos derivados de vitamina D
CN112156097A (zh) 2013-05-29 2021-01-01 博格有限责任公司 使用维生素d预防或减轻化疗诱发的脱发

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA8923B (en) * 1988-01-20 1989-09-27 Hoffmann La Roche 16-dehydro-vitamin d3-derivatives
DK0398217T3 (da) * 1989-05-18 1994-02-14 Hoffmann La Roche Dehydrocholecalciferolderivater
TW267161B (de) * 1992-11-20 1996-01-01 Hoffmann La Roche
US5401733A (en) * 1993-10-01 1995-03-28 Hoffmann-La Roche Inc. Stable and active metabolites of 1,25-dihydroxy-16-ene-cholecalciferol
EP0654476B1 (de) * 1993-11-24 2001-01-24 TARGOR GmbH Metallocene, Verfahren zu ihrer Herstellung und ihrer Verwendung als Katalysatoren
US5428029A (en) * 1993-11-24 1995-06-27 Hoffmann-La Roche Inc. Vitamin D3 fluorinated analogs
US5384314B1 (en) * 1994-03-11 1997-08-05 Hoffmann La Roche 1alpha-fluoro-25-hydroxy-16-ene-23-yne-cholecalciferol
DK0717034T3 (da) * 1994-12-14 1999-10-18 Duphar Int Res Vitamin D-forbindelser og fremgangsmåde til fremstilling af disse forbindelser

Also Published As

Publication number Publication date
EP0884308B1 (de) 2003-04-16
JPH10316652A (ja) 1998-12-02
US6080878A (en) 2000-06-27
ES2196476T3 (es) 2003-12-16
DE69813380D1 (de) 2003-05-22
IL124284A (en) 2004-09-27
DK0884308T3 (da) 2003-07-21
EP0884308A2 (de) 1998-12-16
DE69813380T2 (de) 2003-12-04
EP0884308A3 (de) 1999-05-19

Similar Documents

Publication Publication Date Title
DE69024757D1 (de) Methode zur Herstellung von Taxol unter Verwendung von Oxazinon
ATE346062T1 (de) Verfahren zur herstellung von optisch-aktiven sulfoxid-derivaten
ATE237586T1 (de) Verfahren zur herstellung von 16-dehydro vitamin d verbindungen
ATE207055T1 (de) Verfahren zur herstellung von 4-aryl-3- hydroxymethyl-piperidinen
ATE430144T1 (de) Verfahren zur herstellung von arylethern
ATE261953T1 (de) Verfahren zur herstellung von citalopram
ATE383353T1 (de) Verfahren zur herstellung von 2-alkyl-3- aminothiophen derivate und 3-aminothiophen derivate
EP1484322A4 (de) Verfahren zur herstellung eines optisch aktiven sulfoxid derivats
ATE372332T1 (de) Verfahren zur herstellung von zwischenverbindungen in der herstellung von discodermolid und discodermolid-analoga
ATE191461T1 (de) Verfahren zur herstellung von alkoxyimino acetamid-derivaten
ES2190222T3 (es) Derivados de 3-(2-oxo-(1,3')bipirrolindinil-3-iliden-metil)-cefem.
FR2702220B1 (fr) Dédoublement enzymatique de dérivés de 4-alkyl-2-pipéridine-carboxylate et utilisation des composés obtenus, comme intermédiaires de synthèse.
ES2182317T3 (es) Produccion de compuestos de avermectina.
ATE222902T1 (de) Verfahren zur herstellung von hetero-bizyklischem alkohol-enantiomer
ATE311375T1 (de) Verfahren zur herstellung antiosteoporicagenz
DK0963998T3 (da) Azasteroidforbindelse til behandling eller prævention af prostatacancer
DE69900528D1 (de) Herstellung von Di-tert-peroxiden
ATE293095T1 (de) Verfahren zur herstellung von cyclopropancarboxylaten
DE69101790D1 (de) Verfahren zur Herstellung von Vitamin A Aldehyd.
ATE111456T1 (de) N-alkylthiazolidinderivate.
DE60000890D1 (de) Verfahren zur Herstellung von 1,1,1-Trifluoro-2-aminoalkane
ATE244228T1 (de) Verfahren zur herstellung von chloroacetylaminothiazoleaceticsäure derivate
DE3772703D1 (de) Verfahren zur herstellung von penemen.
ATE59375T1 (de) Verfahren zur herstellung von polyenaldehyden.
DE69919132D1 (de) Verfahren zur herstellung von s-alkylcysteinen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0884308

Country of ref document: EP

REN Ceased due to non-payment of the annual fee